Clinical research organization India
                                                                   Who We Are | Mission | Partners | Operations Team | Board of Directors
                                                                   Overview | Site Feasibility | Regulatory | Our Network | PI and Site Selection | Site Management | MORE
                                                                                                                    What's New | Press Releases | Events
                                                                   ELS Locations | Join Investigator Network | Request Information | Careers
C99
Study Feasibility
Regulatory
Our Network
PI and Site Selection
Site Management
Data Management
GCP Training
Biometrics
Consulting
Press Releases
Testimonials
PI and Site Selection

Excel Life Sciences (ELS) recognizes that the accurate identification of potential study sites is critical to the overall success of any clinical trial. The ELS operations team has a great deal of experience in identifying investigators as well as evaluating site staff, facilities, clinical research expertise and patient demographics. In addition, ELS’ strength in site identification is evaluating the protocol, patient population and available resources in order to develop strategies that will help ensure that only the best locations and sites are presented to our clients for evaluation.

In order to help build a strong foundation for site selection recommendations, ELS will utilize and evaluate its existing network database nearly 1350 investigators and physicians practicing and conducting research throughout India, as well as data on over 1000 research sites. Using robust databases made up of epidemiology information and patient demographics from hospitals, ELS will identify the geographic areas and investigative sites that have the highest prevalence of patients suffering from any one of over 600 conditions. ELS will then overlay that prevalence data with our database of investigators to identify those physicians working within areas of highest prevalence; seeing the most patients annually for a specific condition, as well as those having the greatest clinical trial experience, or capable of becoming successful investigators. This level of data is important as research has shown that sites in patient-rich zones have higher net randomization rates.

Sample ELS investigator & site targeting points:

  • Clinical trials experience
  • Therapeutic specialty
  • Geographic location in relation to disease prevalence
  • Patient demographics & patient load
  • Standard of care
  • Annual office visits by condition
  • Personnel qualifications & thought leadership (KOLs)
  • Facility, equipment and infrastructure specifications
  • IRB meeting frequency, turnaround times and composition
  • Competitive study landscape
  • Accessibility to airports for transport of time-critical lab samples.
  • Experience working with ELS and performance record

In addition, ELS offers our clients:

  • Fast turnaround times: Initial identification reports can be generated in as little as 72 hours
  • Investigative Site Visits and Assessment reports
  • Investigative Site Recruitment Performance Tracking